Search

Your search keyword '"Besch C"' showing total 123 results

Search Constraints

Start Over You searched for: Author "Besch C" Remove constraint Author: "Besch C"
123 results on '"Besch C"'

Search Results

1. Location and allocation: inequity of access to liver transplantation for patients with severe acute‐on‐chronic liver failure in Europe

2. A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis

13. Prognosis of ALF of unknown cause: results of the French multicentre prospective HASIPRO study

14. Primary Prophylaxis with Pyrimethamine for Toxoplasmic Encephalitis in Patients with Advanced Human Immunodeficiency Virus Disease: Results of a Randomized Trial

15. Sofosbuvir-based treatment of hepatitis C with severe fibrosis (METAVIR F3/F4) after liver transplantation results from the CO23 ANRS CUPILT study

16. Treatment and prognosis of acute severe autoimmune hepatitis

17. Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study

18. Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study

19. French Intensive Care Society, International congress - Réanimation 2016

21. Should we keep using Ribavirin to Treat Hepatitis C Recurrence after Liver Transplantation? Results from the CO23 ANRS Cupilt Study

22. Renal Dysfunction in Liver Transplant Patients Treated with Sofosbuvir Based-Regimen for HCV Recurrence: Results from a Large French Prospective Multicentric ANRS CO23 Cupilt

23. Sofosbuvir-Based-Regimen for HCV Recurrence after Combined Liver-Kidney Transplantation : Results from the ANRS CO23 Cupilt Study

24. Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study

26. Safety of sofosbuvir‐based regimens after liver transplantation: longitudinal assessment of renal function in the prospective ANRS CO23 CUPILT study.

27. G15 : The association of sofosbuvir and daclatasvir for treating severe recurrence of HCV infection after liver transplantation: Results from a large french prospective multicentric ANRS CO23 CUPILT cohort

28. FRI-481 - Renal Dysfunction in Liver Transplant Patients Treated with Sofosbuvir Based-Regimen for HCV Recurrence: Results from a Large French Prospective Multicentric ANRS CO23 Cupilt

29. FRI-483 - Sofosbuvir-Based-Regimen for HCV Recurrence after Combined Liver-Kidney Transplantation : Results from the ANRS CO23 Cupilt Study

32. The impact of human immunodeficiency virus infection on drug-resistant tuberculosis

36. Food Safety Knowledge, Beliefs and Behavior of Persons with AIDS: A Multicenter Study.

37. Primary Prophylaxis with Pyrimethamine for Toxoplasmic Encephalitis in Patients with Advanced Human Immunodeficiency Virus Disease: Results of a Randomized Trial.

38. Clinical programs for clinical research on AIDS: Description of a randomized prospective study of clindamycin versus pyrimethamine for prevention of Toxoplasma gondii infection.

40. Predictors of CD4 count change over 8 months of follow up in HIV-1-infected patients with a CD4 count >= 300 cells/mu L who were assigned to 7.5 MIU interleukin-2

41. Location and allocation

42. French Intensive Care Society, International congress – Réanimation 2016

43. Autoimmune hepatitis recurrence after liver transplantation: "Les jeux sont faits".

44. Legionnaires Disease in Solid Organ Transplant Recipients: A Decade-Long Nationwide Study in France.

45. Treatment of donor-specific anti-HLA antibodies-mediated rejection after liver transplantation: A French nationwide retrospective study.

46. Additional value of interleukin-6 level to predict histopathological features of hepatocellular carcinoma before liver transplantation.

47. Long-term outcome of liver transplantation for autoimmune hepatitis: A French nationwide study over 30 years.

48. Liver transplantation for autoimmune hepatitis: Pre-transplant does not predict the early post-transplant outcome.

49. Inevitability of disease recurrence after liver transplantation for NAFLD cirrhosis.

50. Patients Treated for HCV Infection and Listed for Liver Transplantation in a French Multicenter Study: What Happens at Five Years?

Catalog

Books, media, physical & digital resources